![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MRPL50 |
Gene summary for MRPL50 |
![]() |
Gene information | Species | Human | Gene symbol | MRPL50 | Gene ID | 54534 |
Gene name | mitochondrial ribosomal protein L50 | |
Gene Alias | MRP-L50 | |
Cytomap | 9q31.1 | |
Gene Type | protein-coding | GO ID | GO:0000313 | UniProtAcc | Q8N5N7 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
54534 | MRPL50 | LZE4T | Human | Esophagus | ESCC | 1.23e-16 | 3.97e-01 | 0.0811 |
54534 | MRPL50 | LZE7T | Human | Esophagus | ESCC | 1.76e-14 | 7.41e-01 | 0.0667 |
54534 | MRPL50 | LZE8T | Human | Esophagus | ESCC | 1.31e-14 | 5.10e-01 | 0.067 |
54534 | MRPL50 | LZE20T | Human | Esophagus | ESCC | 2.68e-08 | 3.18e-01 | 0.0662 |
54534 | MRPL50 | LZE24T | Human | Esophagus | ESCC | 4.53e-16 | 4.57e-01 | 0.0596 |
54534 | MRPL50 | LZE22D3 | Human | Esophagus | HGIN | 3.07e-02 | 2.68e-01 | 0.0653 |
54534 | MRPL50 | LZE21T | Human | Esophagus | ESCC | 4.72e-03 | 5.53e-01 | 0.0655 |
54534 | MRPL50 | LZE6T | Human | Esophagus | ESCC | 1.20e-16 | 1.06e+00 | 0.0845 |
54534 | MRPL50 | P1T-E | Human | Esophagus | ESCC | 1.21e-05 | 1.41e-01 | 0.0875 |
54534 | MRPL50 | P2T-E | Human | Esophagus | ESCC | 3.51e-26 | 5.48e-01 | 0.1177 |
54534 | MRPL50 | P4T-E | Human | Esophagus | ESCC | 2.63e-37 | 9.87e-01 | 0.1323 |
54534 | MRPL50 | P5T-E | Human | Esophagus | ESCC | 1.40e-21 | 3.10e-01 | 0.1327 |
54534 | MRPL50 | P8T-E | Human | Esophagus | ESCC | 4.18e-17 | 2.40e-01 | 0.0889 |
54534 | MRPL50 | P9T-E | Human | Esophagus | ESCC | 1.43e-25 | 5.97e-01 | 0.1131 |
54534 | MRPL50 | P10T-E | Human | Esophagus | ESCC | 6.22e-30 | 5.14e-01 | 0.116 |
54534 | MRPL50 | P11T-E | Human | Esophagus | ESCC | 2.13e-18 | 6.74e-01 | 0.1426 |
54534 | MRPL50 | P12T-E | Human | Esophagus | ESCC | 1.19e-21 | 4.53e-01 | 0.1122 |
54534 | MRPL50 | P15T-E | Human | Esophagus | ESCC | 5.93e-23 | 4.85e-01 | 0.1149 |
54534 | MRPL50 | P16T-E | Human | Esophagus | ESCC | 2.15e-20 | 3.04e-01 | 0.1153 |
54534 | MRPL50 | P17T-E | Human | Esophagus | ESCC | 3.80e-11 | 5.19e-01 | 0.1278 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MRPL50 | SNV | Missense_Mutation | novel | c.146N>A | p.Ile49Asn | p.I49N | Q8N5N7 | protein_coding | tolerated(0.12) | benign(0.054) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
MRPL50 | SNV | Missense_Mutation | novel | c.161N>A | p.Pro54His | p.P54H | Q8N5N7 | protein_coding | deleterious(0) | probably_damaging(0.956) | TCGA-AX-A1CE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | SD |
MRPL50 | SNV | Missense_Mutation | rs544635589 | c.283C>T | p.Arg95Cys | p.R95C | Q8N5N7 | protein_coding | deleterious(0.03) | possibly_damaging(0.761) | TCGA-D1-A16X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
MRPL50 | SNV | Missense_Mutation | novel | c.46T>C | p.Trp16Arg | p.W16R | Q8N5N7 | protein_coding | tolerated_low_confidence(0.27) | benign(0.001) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
MRPL50 | insertion | Frame_Shift_Ins | rs755588721 | c.450_451insC | p.Asn151GlnfsTer24 | p.N151Qfs*24 | Q8N5N7 | protein_coding | TCGA-BS-A0TA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | taxol | PD | ||
MRPL50 | SNV | Missense_Mutation | c.413N>T | p.Ser138Phe | p.S138F | Q8N5N7 | protein_coding | deleterious(0) | possibly_damaging(0.9) | TCGA-78-7536-01 | Lung | lung adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD | |
MRPL50 | SNV | Missense_Mutation | novel | c.456N>C | p.Leu152Phe | p.L152F | Q8N5N7 | protein_coding | deleterious(0.01) | probably_damaging(0.939) | TCGA-56-8625-01 | Lung | lung squamous cell carcinoma | Female | >=65 | III/IV | Chemotherapy | cisplatin | PD |
MRPL50 | SNV | Missense_Mutation | rs772196147 | c.391N>G | p.Asn131Asp | p.N131D | Q8N5N7 | protein_coding | tolerated(0.19) | benign(0.062) | TCGA-F7-A624-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
MRPL50 | SNV | Missense_Mutation | novel | c.244N>G | p.Leu82Val | p.L82V | Q8N5N7 | protein_coding | tolerated(0.71) | benign(0.003) | TCGA-IQ-A61H-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
MRPL50 | SNV | Missense_Mutation | c.471T>A | p.Ser157Arg | p.S157R | Q8N5N7 | protein_coding | tolerated(0.08) | benign(0.124) | TCGA-BR-8361-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |